Cullinan Oncology
CGEM
CGEM
66 hedge funds and large institutions have $762M invested in Cullinan Oncology in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 33 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
-5
Holders Change %
-7.04%
% of All Funds
1.16%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
33
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$51.5M |
| 2 |
BlackRock
New York
|
$36.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
$56.4M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
$9.51M |
| 5 |
Goldman Sachs
New York
|
$3.56M |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
$0 |
| 2 |
VA
VR Adviser
New York
|
$15.9M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
$173M |
| 4 |
EP
Eversept Partners
New York
|
$0 |
| 5 |
PVI
Pura Vida Investments
New York
|
$1.84M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Lazard Asset Management
New York
| – | -$58K | -2,273 | Closed |
|
|
S
77
SignatureFD
Atlanta,
Georgia
| – | -$1K | -29 | Closed |
|